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Citrus tristeza virus (CTV) causes a most destructive citrus disease in many parts of the world and several approaches have been 
used to control damages like eradication programs, use of tolerant or resistant rootstock, use of transgenic Citrus and cross 
protection. The aim of this study was to identify, by a computational approach, molecules that interfere with CTV replication. Drug 
discovery is an extended process that can take as many as 15 years from the first compound synthesis in the laboratory until the
therapeutic agent, or drug, is brought to market. GriDock is a molecular modelling software developed to identify potentially 
bioactive compounds (hit-compounds) in order to speed-up the drug discovery process. It's based on the virtual-screening 
approach in which the activity of a large set of molecules is predicted by multiple molecular docking calculations. With a view to 
verify its potentialities, the RdRp (RNA dependent RNA polymerase) enzyme of CTV was chosen as a potential target. RdRp 3D 
structure was obtained through homology approaches. The screening of more than one million of molecules allowed the 
identification of some potential RdRp inhibitors. Sulfonic acids and penicillin derivatives were selected and an in vitro assay to test 
their activities was developed. Results must be considered preliminary but of great interest for a novel and innovative approach to 
study CTV replication rate, biology and plant interactions.
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Computational details
•We developed a new parallel structure-based virtual screening
software (GriDock) able to run on both multi-CPU and GRID 
systems
•It’s a front-end to the well known AutoDock software, 
developed by D.S. Goodsel and A.J. Olson
•It uses VEGA command-line software to perform file format 
conversion, database extraction and molecular property 
calculations
• It can take full advantages of multi-CPUs/cores systems and 
GRID-based architectures through its parallel design (Fig.1). 
We screened about 1 million molecules included in the ligand
info database (http://ligand.info) principally derived from drugs. Fig. 1 GriDock combines the VEGA flexibility and the AutoDock 4 
power to take full advantage of the Grid technology
Experimental details
Citrange troyer discs leaf samples (2mm2) infected with SG29 
isolate, were maintained in liquid medium, in growth chamber 
for 14 days with 20000 lux for 16 hours at 28°C, 8 hou rs dark 
at 23°C, humidity 70%. Two selected drugs were test ed in 
three different concentrations (0,1%, 0,2%, 0,3%). No treated 
leafs were used as internal control. RNAs were isolate and 
the cDNAs were synthetized.  
Real-Time PCR
Replication rate of CTV was tested by the comparative Ct 
method (DDCT). As reference gene, eukaryotic elongation 
factor was chosen. For CTV relative quantification partial UTR 
region was amplified using primers and probe described by 
Bertolini et al. (2008) [3].
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Fig.2 Binding of a sulfonic acid on RdRp
Results
•The complete RdRp model required by GriDock was 
obtained by the homology modeling approach
•Selected molecules target contain sulfur atoms and multiple 
sulfonic acid moieties
•Some of them are included in the Anti-HIV class
•A sensible inhibition of viral replication was obtained
Results obtained by in vitro tests, although in a preliminary 
phase, confirmed the in silico approach results. In the next 
future molecules have to be tested in plants for in vivo
exsperimentation. More compounds and CTV proteins could 
be explored. 0
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Fig. 3 Inhibition of viral replication rate by real-time PCR. Nt: not treated; 
Pen: penicillin derivative (0,1-0,2-0,3% w/v); Sul: sulfonic acid derivative 
(0,1-0,2-0,3% w/v)  
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